In conclusion, we show that Dextramers to detect α-gliadin-specific CD4+ TEM can accurately identify most celiac disease patients irrespective of the use of a (self-initiated) GFD and that this test is methodologically feasible in a specialized laboratory setting. This evidence concerns the gene CD4 and celiac disease.